Harnessing Bee Venom to Kill Tumour Cells: Revolutionary Breakthrough in Cancer Treatment

Scientists at Washington University have made a groundbreaking discovery in cancer treatment by harnessing the power of bee venom to kill tumour cells. Researchers have developed nano-sized spheres, called nanobees, which contain the major component of bee venom, melittin. This potent toxin selectively targets and destroys cancer cells while protecting healthy tissues.

Key Takeaways:

• The researchers successfully attached melittin, a small protein found in bee venom, to nanobees, which are nano-sized spheres designed to deliver the toxin to tumour cells.
• Experiments on mice showed that nanobees delivered melittin to tumours, resulting in a significant reduction in tumour growth and size.
• The study reveals that melittin is an effective anticancer agent, capable of killing cancer cells by forming pores in their membranes and breaking them up.
• Researchers tested nanobees in two types of mice with cancerous tumours, with breast cancer and melanoma cells, and observed a significant reduction in tumour growth.
• In one study, the growth of breast cancer tumours slowed by nearly 25% after four to five injections of melittin-carrying nanoparticles over several days.
• The nanobees also showed promise in targeting pre-cancerous skin lesions, reducing the extent of proliferation of pre-cancerous skin cells in mice by 80%.

Statistics:

• 25% reduction in tumour growth in breast cancer tumours after four to five injections of melittin-carrying nanoparticles.
• 88% decrease in the size of melanoma tumours compared to untreated tumours.
• 80% reduction in the extent of proliferation of pre-cancerous skin cells in mice treated with targeted nanobees.

Sources:

• Washington University researchers, as published in the online edition of the Journal of Clinical Investigation.
• Dr. Samuel Wickline, co-author and head of the Siteman Center of Cancer Nanotechnology Excellence at Washington University.
• Dr. Paul Schlesinger, co-author and associate professor of cell biology and physiology at Washington University.